The UC Santa Cruz Colligan Clinical Diagnostic Laboratory (CCDL) has received its CLIA certificate of registration from the California Department of Public Health, which clears the way for it to begin ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...

PSA stands for prostate-specific antigen, a substance naturally produced in prostate tissue. A small amount of PSA regularly sneaks into the bloodstream, and low blood concentration is considered ...

When Christy Fennewald was 36, she felt a lump in one of her breasts, but a diagnostic ultrasound didn't pick up that it was suspicious. Nine months later, she was diagnosed with breast cancer and ...

The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...

A pair of well-known marijuana compounds work in tandem to target ovarian cancer cells In A Nutshell CBD and THC killed ovarian cancer cells at low doses while normal cells required 4-5 times higher ...

Overcoming acquired treatment resistance is one of the major challenges in the fight against cancer. While combination therapies hold promise, their toxicity to healthy tissue remains a major hurdle.

Cancer continues to be one of the world's top causes of death, partly because of delayed discovery of the disease. But according to a recently released study, a simple blood test may be able to ...

Engineering professors at the University are creating a new kind of lab-grown cancer tumor that will make cancer research more accessible and affordable, revolutionizing the field. Bioengineering ...

Researchers have created tiny metal-based particles that push cancer cells over the edge while leaving healthy cells mostly unharmed. The particles work by increasing internal stress in cancer cells ...